MedTrace Logo

The Modulatory Effect of Oxytocin on Interoception

NCT03074409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2019-10-18

Study results available
· View outcomes & findings →

Summary

This study is designed to investigate oxytocin's effects on interoception and whether these effects vary as a function of different emotional valence.

Conditions

  • Interoception

Interventions

DRUG

oxytocin

self-administration of oxytocin (nasal spray)

DRUG

placebo

self-administration of placebo (nasal spray)

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Keith Kendrick, PhD · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-02
Primary Completion
2017-09-06
Completion
2017-09-12

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03074409 on ClinicalTrials.gov